for untreated and rapamycin treated conditions. Both are expressed in log2 ratio. (TIF) Acknowledgments We thank Dr. Sigrid Laure Rouam for performing statistical analysis of the correlations. References 1. Dowling RJ, Pollak M, Sonenberg N (2009) Current status and challenges associated with targeting mTOR for cancer therapy. Bio Drugs 23: 77–91. 2. De Virgilio C, Loewith R (2006) The TOR signalling network from yeast to man. Int J Biochem Cell Biol 38: 1476–1481. 3. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471–484. 4. Martin DE, Soulard A, Hall MN (2004) TOR regulates ribosomal protein gene expression via PKA and the Forkhead transcription factor FHL1. Cell 119: 969–979. 5. Duvel K, Santhanam A, Garrett S, Schneper L, Broach JR (2003) Multiple roles of Tap42 in mediating rapamycin-induced transcriptional changes in yeast. Mol Cell 11: 1467–1478. 6. Jacinto E, Guo B, Arndt KT, Schmelzle T, Hall MN (2001) TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway. Mol Cell 8: 1017–1026. 7. Jacinto E, Hall MN (2003) Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol 4: 117–126. 8. Uffenbeck SR, Krebs JE (2006) The role of chromatin structure in regulating stress-induced transcription in Saccharomyces cerevisiae. Biochem Cell Biol 84: 477–489. 9. Huisinga KL, Pugh BF (2004) A genome-wide housekeeping role for TFIID and a highly regulated stress-related role for SAGA in Saccharomyces cerevisiae. Mol Cell 13: 573–585. 10. Chan TF, Carvalho J, Riles L, Zheng XF (2000) A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR). Proc Natl Acad Sci U S A 97: 13227–13232. 11. Neklesa TK, Davis RW (2008) Superoxide anions regulate TORC1 and its ability to bind Fpr1:rapamycin complex. Proc Natl Acad Sci U S A 105: 15166–15171. 12. Xie MW, Jin F, Hwang H, Hwang S, Anand V, et al. (2005) Insights into TOR function and rapamycin response: chemical genomic profiling by using a high- density cell array method. Proc Natl Acad Sci U S A 102: 7215–7220. 13. Rempola B, Kaniak A, Migdalski A, Rytka J, Slonimski PP, et al. (2000) Functional analysis of RRD1 (YIL153w) and RRD2 (YPL152w), which encode two putative activators of the phosphotyrosyl phosphatase activity of PP2A in Saccharomyces cerevisiae. Mol Gen Genet 262: 1081–1092. 14. Jordens J, Janssens V, Longin S, Stevens I, Martens E, et al. (2006) The Protein Phosphatase 2A Phosphatase Activator Is a Novel Peptidyl-Prolyl cis/trans- Isomerase. J Biol Chem 281: 6349–6357. 15. Cayla X, Goris J, Hermann J, Hendrix P, Ozon R, et al. (1990) Isolation and characterization of a tyrosyl phosphatase activator from rabbit skeletal muscle and Xenopus laevis oocytes. Biochemistry 29: 658–667. 16. Cayla X, Van Hoof C, Bosch M, Waelkens E, Vandekerckhove J, et al. (1994) Molecular cloning, expression, and characterization of PTPA, a protein that activates the tyrosyl phosphatase activity of protein phosphatase 2A. J Biol Chem 269: 15668–15675. 17. Fellner T, Lackner DH, Hombauer H, Piribauer P, Mudrak I, et al. (2003) A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivo. Genes Dev 17: 2138–2150. 18. Hombauer H, Weismann D, Mudrak I, Stanzel C, Fellner T, et al. (2007) Generation of active protein phosphatase 2A is coupled to holoenzyme assembly. PLoS Biol 5: e155. 19. Zheng Y, Jiang Y (2005) The yeast phosphotyrosyl phosphatase activator is part of the Tap42-phosphatase complexes. Mol Biol Cell 16: 2119–2127. 20. Douville J, David J, Lemieux KM, Gaudreau L, Ramotar D (2006) The Saccharomyces cerevisiae phosphatase activator RRD1 is required to modulate gene expression in response to rapamycin exposure. Genetics 172: 1369–1372. 21. Lempiainen H, Shore D (2009) Growth control and ribosome biogenesis. Curr Opin Cell Biol 21: 855–863. 22. Jouvet N, Poschmann J, Douville J, Bulet L, Ramotar D Rrd1 isomerizes RNA polymerase II in response to rapamycin. BMC Mol Biol 11: 92. 23. Kops O, Zhou XZ, Lu KP (2002) Pin1 modulates the dephosphorylation of the RNA polymerase II C-terminal domain by yeast Fcp1. FEBS Lett 513: 305–311. 24. Singh N, Ma Z, Gemmill T, Wu X, Defiglio H, et al. (2009) The Ess1 prolyl isomerase is required for transcription termination of small noncoding RNAs via the Nrd1 pathway. Mol Cell 36: 255–266. 25. Wu X, Rossettini A, Hanes SD (2003) The ESS1 prolyl isomerase and its suppressor BYE1 interact with RNA pol II to inhibit transcription elongation in Saccharomyces cerevisiae. Genetics 165: 1687–1702. Rrd1 Regulates Elongation of RNA Polymerase II Author Contributions Conceived and designed the experiments: JP DR. Performed the experiments: JP SD KEF MN. Analyzed the data: JP SD P-EJ KEF FR DR. Contributed reagents/materials/analysis tools: FR DR. Wrote the paper: JP FR DR. 26. Xu YX, Hirose Y, Zhou XZ, Lu KP, Manley JL (2003) Pin1 modulates the structure and function of human RNA polymerase II. Genes Dev 17: 2765–2776. 27. Xu YX, Manley JL (2007) Pin1 modulates RNA polymerase II activity during the transcription cycle. Genes Dev 21: 2950–2962. 28. Buratowski S (2003) The CTD code. Nat Struct Biol 10: 679–680. 29. Phatnani HP, Greenleaf AL (2006) Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev 20: 2922–2936. 30. Cho EJ (2007) RNA polymerase II carboxy-terminal domain with multiple connections. Exp Mol Med 39: 247–254. 31. Egloff S, Murphy S (2008) Cracking the RNA polymerase II CTD code. Trends Genet 24: 280–288. 32. Hardwick JS, Kuruvilla FG, Tong JK, Shamji AF, Schreiber SL (1999) Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc Natl Acad Sci U S A 96: 14866–14870. 33. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863–14868. 34. Berriz GF, Beaver JE, Cenik C, Tasan M, Roth FP (2009) Next generation software for functional trend analysis. Bioinformatics 25: 3043–3044. 35. Gasch AP, Spellman PT, Kao CM, Carmel-Harel O, Eisen MB, et al. (2000) Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 11: 4241–4257. 36. Kulish D, Struhl K (2001) TFIIS enhances transcriptional elongation through an artificial arrest site in vivo. Mol Cell Biol 21: 4162–4168. 37. Ramotar D, Belanger E, Brodeur I, Masson JY, Drobetsky EA (1998) A yeast homologue of the human phosphotyrosyl phosphatase activator PTPA is implicated in protection against oxidative DNA damage induced by the model carcinogen 4-nitroquinoline 1-oxide. J Biol Chem 273: 21489–21496. 38. Aureliano M, Crans DC (2009) Decavanadate (V10 O28 6-) and oxovanadates: oxometalates with many biological activities. J Inorg Biochem 103: 536–546. 39. Wysocki R, Fortier PK, Maciaszczyk E, Thorsen M, Leduc A, et al. (2004) Transcriptional activation of metalloid tolerance genes in Saccharomyces cerevisiae requires the AP-1-like proteins Yap1p and Yap8p. Mol Biol Cell 15: 2049–2060. 40. Ghavi-Helm Y, Michaut M, Acker J, Aude JC, Thuriaux P, et al. (2008) Genome-wide location analysis reveals a role of TFIIS in RNA polymerase III transcription. Genes Dev 22: 1934–1947. 41. Cheung AC, Cramer P Structural basis of RNA polymerase II backtracking, arrest and reactivation. Nature. 42. Rohde JR, Bastidas R, Puria R, Cardenas ME (2008) Nutritional control via Tor signaling in Saccharomyces cerevisiae. Curr Opin Microbiol 11: 153–160. 43. Schawalder SB, Kabani M, Howald I, Choudhury U, Werner M, et al. (2004) Growth-regulated recruitment of the essential yeast ribosomal protein gene activator Ifh1. Nature 432: 1058–1061. 44. Wade JT, Hall DB, Struhl K (2004) The transcription factor Ifh1 is a key regulator of yeast ribosomal protein genes. Nature 432: 1054–1058. 45. Longin S, Jordens J, Martens E, Stevens I, Janssens V, et al. (2004) An inactive protein phosphatase 2A population is associated with methylesterase and can be re-activated by the phosphotyrosyl phosphatase activator. Biochem J 380: 111–119. 46. Riles L, Shaw RJ, Johnston M, Reines D (2004) Large-scale screening of yeast mutants for sensitivity to the IMP dehydrogenase inhibitor 6-azauracil. Yeast 21: 241–248. 47. Exinger F, Lacroute F (1992) 6-Azauracil inhibition of GTP biosynthesis in Saccharomyces cerevisiae. Curr Genet 22: 9–11. 48. Shaw RJ, Reines D (2000) Saccharomyces cerevisiae transcription elongation mutants are defective in PUR5 induction in response to nucleotide depletion. Mol Cell Biol 20: 7427–7437. 49. Morillon A, Karabetsou N, O’Sullivan J, Kent N, Proudfoot N, et al. (2003) Isw1 chromatin remodeling ATPase coordinates transcription elongation and termination by RNA polymerase II. Cell 115: 425–435. 50. Pelechano V, Jimeno-Gonzalez S, Rodriguez-Gil A, Garcia-Martinez J, Perez- Ortin JE, et al. (2009) Regulon-specific control of transcription elongation across the yeast genome. PLoS Genet 5: e1000614. 51. Gasch AP (2007) Comparative genomics of the environmental stress response in ascomycete fungi. Yeast 24: 961–976. 52. Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, et al. (2000) Genome- wide location and function of DNA binding proteins. Science 290: 2306–2309. PLoS ONE | www.plosone.org 13 August 2011 | Volume 6 | Issue 8 | e23159